Somatically acquired biallelic MLH1 methylation in CRC results in loss of immunohistochemical expression of the MLH1 and PMS2 DNA mismatch repair (MMR) proteins and microsatellite instability within the tumour (i.e. MMR-deficiency). This evidence concerns the gene MLH1 and neoplasm.